Lincoln Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE405C01035
  • NSEID: LINCOLN
  • BSEID: 531633
INR
511.05
-0.85 (-0.17%)
BSENSE

Nov 20

BSE+NSE Vol: 16.09 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 294056,
    "name": "Lincoln Pharma.",
    "stock_name": "Lincoln Pharma.",
    "full_name": "Lincoln Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/lincoln-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "511.05",
    "chg": -0.85,
    "chgp": "-0.17%",
    "dir": -1,
    "prev_price": "511.90",
    "mcapval": "1,021.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531633,
    "symbol": "LINCOLN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE405C01035",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "16.09 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4268710",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/LincolnPharmace_technicaldot_4268710.png",
        "date": "2026-11-20 08:00:48",
        "description": "Lincoln Pharmaceuticals Ltd has experienced a subtle yet significant shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. This transition is underscored by a complex interplay of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced market sentiment for this micro-cap pharmaceutical stock."
      },
      {
        "title": "Lincoln Pharmaceuticals Declines 2.48%: 6 Key Factors Shaping This Week’s Volatility",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lincoln-pharmaceuticals-declines-248-6-key-factors-shaping-this-weeks-volatility-4246226",
        "imagepath": "",
        "date": "2026-11-01 10:00:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Downgrade to Sell amid technical weakness and modest growth</p>\n                    <p><strong>27 Oct:</strong> Technical momentum shifts to bearish amid mixed signals</p>\n                    <p><strong>28 Oct:</strong> Technical momentum shows mild improvement but remains cautious</p>\n                    <p><strong>29 Oct:</strong> Flat quarterly performance reported with margin contraction</p>\n                    <p><strong>30 Oct:</strong> Further technical downgrade and valuation shifts to attractive</p>\n                    <p><strong>30 Oct:</strong> Week closes at ₹501.95 (-2.48%) vs Sensex +2.12%</p>\n                </div>\n\n                <div class=\"stats..."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-faces-bearish-momentum-amid-technical-downgrade-4243811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LincolnPharmace_technicaldot_4243811.png",
        "date": "2026-10-30 08:00:50",
        "description": "Lincoln Pharmaceuticals Ltd has experienced a significant shift in its technical momentum, prompting a downgrade from Hold to Sell by MarketsMojo on 28 Oct 2026. The micro-cap pharmaceutical company’s shares have declined sharply, reflecting deteriorating technical indicators and bearish signals across multiple timeframes."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Valuation Shifts to Attractive Amid Market Pressure",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-valuation-shifts-to-attractive-amid-market-pressure-4243808",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LincolnPharmace_valuationdot_4243808.png",
        "date": "2026-10-30 08:00:48",
        "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This article analyses the company’s current price attractiveness in the context of its historical performance, peer comparisons, and broader market trends."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Reports Flat Quarterly Performance Amid Margin Pressure",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-reports-flat-quarterly-performance-amid-margin-pressure-4243693",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LincolnPharmace_fintrenddot_4243693.png",
        "date": "2026-10-29 16:00:06",
        "description": "Lincoln Pharmaceuticals Ltd has reported a flat financial performance for the quarter ended September 2026, marking a significant shift from its previously positive growth trajectory. Despite achieving its highest quarterly net sales to date, the company faced considerable margin contraction and profit pressures, prompting a downgrade in its Mojo Grade from Hold to Sell."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4241412",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LincolnPharmace_technicaldot_4241412.png",
        "date": "2026-10-28 08:01:38",
        "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a strong day gain of 4.37%, the stock’s broader technical signals suggest caution as mixed readings from MACD, RSI, moving averages, and other momentum indicators paint a nuanced picture for investors."
      },
      {
        "title": "Lincoln Pharmaceuticals Downgraded to Sell Amid Technical Weakness and Modest Growth",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/lincoln-pharmaceuticals-downgraded-to-sell-amid-technical-weakness-and-modest-growth-4238402",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LincolnPharmace_mojoScore_4238402.png",
        "date": "2026-10-26 08:06:02",
        "description": "Lincoln Pharmaceuticals Ltd has seen its investment rating downgraded from Hold to Sell, driven primarily by deteriorating technical indicators and subdued long-term financial growth. Despite some positive quarterly results and a net-debt-free balance sheet, the company’s overall outlook has weakened, prompting a reassessment of its quality, valuation, financial trend, and technical parameters."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Technical Momentum Shifts to Bearish Amid Mixed Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-technical-momentum-shifts-to-bearish-amid-mixed-signals-4238127",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/LincolnPharmace_technicaldot_4238127.png",
        "date": "2026-10-26 08:00:36",
        "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating reflects deteriorating technical conditions, despite a modest price increase on 26 Oct 2026. Investors should carefully analyse the evolving chart patterns and momentum oscillators before making decisions."
      },
      {
        "title": "Lincoln Pharmaceuticals Declines 5.82%: Death Cross and Technical Weakness Define Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/lincoln-pharmaceuticals-declines-582-death-cross-and-technical-weakness-define-week-4237939",
        "imagepath": "",
        "date": "2026-10-25 11:00:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Oct 19:</strong> Technical momentum shifts to mildly bearish amid mixed market signals</p>\n                    <p><strong>Oct 23:</strong> Death Cross formation signals potential bearish trend</p>\n                    <p><strong>Oct 23:</strong> Week closes at Rs.514.70 (-5.82%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.546.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.514.70</div><div class=\"stat-change negative\">-5.82%</div></div>\n                    <div class=\"stat-it..."
      }
    ],
    "total": 82,
    "sid": "294056",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/lincoln-pharmaceuticals-294056"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Oct-2026",
      "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 we enclosed herewith the copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Financial Results For The Quarter And Half Year Ended On September 30 2026.",
      "datetime": "29-Oct-2026",
      "details": "Un-Audited Financial Results For the Quarter and Half year Ended on September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Un-Audited Financial Results For The Quarter And Half Year Ended On September 30 2026.",
      "datetime": "29-Oct-2026",
      "details": "Un-Audited Financial Results For the Quarter and Half Year ended on September 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 11 Sep 26",
          "dt": "2026-09-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09",
          "dt": "2009-03-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

30-Oct-2026 | Source : BSE

Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 we enclosed herewith the copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on September 30 2026.

Un-Audited Financial Results For The Quarter And Half Year Ended On September 30 2026.

29-Oct-2026 | Source : BSE

Un-Audited Financial Results For the Quarter and Half year Ended on September 30 2026.

Board Meeting Outcome for Board Meeting Outcome For Un-Audited Financial Results For The Quarter And Half Year Ended On September 30 2026.

29-Oct-2026 | Source : BSE

Un-Audited Financial Results For the Quarter and Half Year ended on September 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Lincoln Pharmaceuticals Ltd has declared 18% dividend, ex-date: 11 Sep 26

stock-summary
SPLITS

Lincoln Pharmaceuticals Ltd has announced 10:2 stock split, ex-date: 19 Mar 09

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available